Skip to content

Prevention of preterm birth

Three-arm randomised trial of cervical cerclage, arabin pessary and vaginal progesterone to prevent spontaneous preterm birth in asymptomatic women at high-risk of preterm birth: A feasibility study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11186205
Enrollment
39
Registered
2016-03-10
Start date
2015-10-06
Completion date
Unknown
Last updated
2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Reproductive Health

Interventions

Participants are randomly allocated to receive one of three treatments: 1. Arabin pessary: silicone cerclage pessary device sited around cervix in clinic 2. Cervical cerclage: Macdonald technique to s

Sponsors

University of Liverpool (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or older 2. Singleton pregnancy 3. Between 16+0 – 24+6 weeks in current pregnancy 4. History of previous spontaneous preterm birth (sPTB) or premature rupture of membranes (PPROM) between 16-33+6 AND 5. Cervical length at least <3rd centile for gestational age OR 6. History of significant cervical surgery defined as two large loop excision of the transformation zone (LLETZ) procedures or a single knife cone biopsy (KCB) where a clinical decision is made to treat the short cervix 7. Clinical equipoise as to what is the best treatment

Exclusion criteria

Exclusion criteria: 1. Known or suspected structural or chromosomal fetal abnormality 2. Inability to give informed consent 3. Treatment with history indicated cerclage 4. Treatment with vaginal progesterone within two weeks of randomisation 5. All contraindications to use of progesterone (see protocol 6.2)

Design outcomes

Primary

MeasureTime frame
Feasibility is measured at 12 months post recruitment, with follow up until final mother and baby discharge or 6 weeks postnatal.

Secondary

MeasureTime frame
1. Economic analysis is completed at 12 months post recruitment 2. Patient and staff acceptability is measured 1-2 months post study completion

Countries

United Kingdom

Contacts

Public ContactEdiri O'Brien

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026